Craiglow BG - Search Results

1

Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata.

Bayart CB, DeNiro KL, Brichta L, Craiglow BG, Sidbury R. Bayart CB, et al. Among authors: craiglow bg. J Am Acad Dermatol. 2017 Jul;77(1):167-170. doi: 10.1016/j.jaad.2017.03.024. J Am Acad Dermatol. 2017. PMID: 28619556 No abstract available.

2

Pediatric dermatology workforce shortage: perspectives from academia.

Craiglow BG, Resneck JS Jr, Lucky AW, Sidbury R, Yan AC, Resnick SD, Antaya RJ. Craiglow BG, et al. J Am Acad Dermatol. 2008 Dec;59(6):986-9. doi: 10.1016/j.jaad.2008.08.036. Epub 2008 Oct 2. J Am Acad Dermatol. 2008. PMID: 18835061

3

Killing two birds with one stone: oral tofacitinib reverses alopecia universalis in a patient with plaque psoriasis.

Craiglow BG, King BA. Craiglow BG, et al. J Invest Dermatol. 2014 Dec;134(12):2988-2990. doi: 10.1038/jid.2014.260. Epub 2014 Jun 18. J Invest Dermatol. 2014. PMID: 24940651 Free article. No abstract available.

4

Tofacitinib Citrate for the Treatment of Vitiligo: A Pathogenesis-Directed Therapy.

Craiglow BG, King BA. Craiglow BG, et al. JAMA Dermatol. 2015 Oct;151(10):1110-2. doi: 10.1001/jamadermatol.2015.1520. JAMA Dermatol. 2015. PMID: 26107994

5

Dominant de novo DSP mutations cause erythrokeratodermia-cardiomyopathy syndrome.

Boyden LM, Kam CY, Hernández-Martín A, Zhou J, Craiglow BG, Sidbury R, Mathes EF, Maguiness SM, Crumrine DA, Williams ML, Hu R, Lifton RP, Elias PM, Green KJ, Choate KA. Boyden LM, et al. Among authors: craiglow bg. Hum Mol Genet. 2016 Jan 15;25(2):348-57. doi: 10.1093/hmg/ddv481. Epub 2015 Nov 24. Hum Mol Genet. 2016. PMID: 26604139 Free PMC article.

6

Topical Ruxolitinib for the Treatment of Alopecia Universalis.

Craiglow BG, Tavares D, King BA. Craiglow BG, et al. JAMA Dermatol. 2016 Apr;152(4):490-1. doi: 10.1001/jamadermatol.2015.4445. JAMA Dermatol. 2016. PMID: 26649829 No abstract available.

7

Health-related quality of life (HRQoL) among patients with alopecia areata (AA): A systematic review.

Liu LY, King BA, Craiglow BG. Liu LY, et al. Among authors: craiglow bg. J Am Acad Dermatol. 2016 Oct;75(4):806-812.e3. doi: 10.1016/j.jaad.2016.04.035. Epub 2016 Jul 16. J Am Acad Dermatol. 2016. PMID: 27436156 Review.

8

Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata.

Kennedy Crispin M, Ko JM, Craiglow BG, Li S, Shankar G, Urban JR, Chen JC, Cerise JE, Jabbari A, Winge MC, Marinkovich MP, Christiano AM, Oro AE, King BA. Kennedy Crispin M, et al. Among authors: craiglow bg. JCI Insight. 2016 Sep 22;1(15):e89776. doi: 10.1172/jci.insight.89776. JCI Insight. 2016. PMID: 27699252 Free PMC article.

9

Tofacitinib for the treatment of alopecia areata and variants in adolescents.

Craiglow BG, Liu LY, King BA. Craiglow BG, et al. J Am Acad Dermatol. 2017 Jan;76(1):29-32. doi: 10.1016/j.jaad.2016.09.006. Epub 2016 Nov 2. J Am Acad Dermatol. 2017. PMID: 27816292

10

Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients.

Liu LY, Craiglow BG, Dai F, King BA. Liu LY, et al. Among authors: craiglow bg. J Am Acad Dermatol. 2017 Jan;76(1):22-28. doi: 10.1016/j.jaad.2016.09.007. Epub 2016 Nov 2. J Am Acad Dermatol. 2017. PMID: 27816293

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters